Usefulness of Ivermectin in COVID-19 Illness
Links to relevant documents
Updated, July 8, 2020
Updated, June 26 2020
New:
INCLUSIÓN DE LA IVERMECTINA EN LA PRIMERA LÍNEA DE ACCIÓN TERAPÉUTICA PARA COVID-19Se reporta una muy significativa disminución de la Tasa de Letalidad con su uso
Gustavo Aguirre Chang. Médico egresado de la UNMSM, con Post Grados en Gestión y Salud Ocupacional. Lima, Perú. 2 de Mayo del 2020.
Ver Documento aquí.
Anexos:
- Anexo 1. Laboratorio, Fases, Etapas, Lugar de Atención.
- Anexo 2. Plan terapeutico y terapias potenciales
- Tabla 3. Nuevo esquema terapeutico con Ivermectina
![]() |
Anexo 2. Plan Terapeutico |
![]() |
Tratamiento preventivo con Ivermectina |
--
Updated May 8, 2020 (in Spanish).
English version:INCLUSION OF IVERMECTIN IN THE FIRST THERAPEUTIC LINE OF ACTION FOR COVID-19 A very significant decrease in the Mortality Rate is reported with its use
Gustavo Aguirre Chang. Médico egresado de la UNMSM, con Post Grados en Gestión y Salud Ocupacional. Lima, Perú. 2 de Mayo del 2020.
https://covidcandy.com/treatments-and-cures/cures/gold-standard-ivermectin-protocol/
Abstract:
The existing evidence regarding the use of Ivermectin in COVID-19 is reviewed. A report is also made of the cases treated at the local level.
A study recently published in the journal Antiviral Research obtained participants from 169 hospitals around the world, this study includes a high number of patients treated with Ivermectin: 704 and their corresponding 704 controls. The study results indicate that the case fatality rate in patients who used Ivermectin was 6.1 times less compared to patients who did not use Ivermectin (1.4 vs. 8.5%, p <0.0001).
In the Dominican Republic, the Pulmonologist J. Tavares reports that he is treating 247 patients with Ivermectin with a favorable response in all cases and has not reported any fatal cases.
Similarly, at the local level, although to date there are not many documented cases, the case fatality rate has been 0% and it is also observed that in 100% of the cases treated with Ivermectin there is an improvement in the illness and resolution of fever within 48 hours of starting treatment.
A new therapeutic scheme is presented according to the degree of severity and response to treatment, prepared based on the experience of patients treated locally. In the final part, an evaluation of the Risk-Benefit of the use of Ivermectin is made, the conclusion is given that, since there is practically no risk in its use, it is recommended to formalize its inclusion in the first line of therapeutic action for COVID-19.
Finally, Recommendations are given mainly related to the supply in Health Establishments throughout the country.
--
Peru approves Ivermectin for COVID-19:
Modifican el Documento Técnico: Prevención, Diagnóstico y Tratamiento de
personas afectadas por COVID-19 en el Perú resolución ministerial N 270-2020-MINSA.
https://busquedas.elperuano.pe/normaslegales/modifican-el-documento-tecnico-prevencion-diagnostico-y-tr-resolucion-ministerial-n-270-2020-minsa-1866159-4/
1. Clinical Trials
- https://www.medrxiv.org/content/10.1101/2020.06.06.20124461v2 ICON (Ivermectin in COvid Nineteen) study: Use of Ivermectin is Associated with Lower Mortality in Hospitalized Patients with COVID19 Juliana Cepelowicz Rajter, Michael Sherman, Naaz Fatteh, Fabio Vogel, Jamie Sacks, Jean-Jacques Rajter doi: https://doi.org/10.1101/2020.06.06.20124461
- https://clinicaltrials.gov/ct2/show/NCT04434144 https://www.researchgate.net/publication/342159343_A_comparative_observational_study_on_Ivermectin-_Doxycycline_and_Hydroxychloroquine-Azithromycin_therapy_on_COVID19_patients Taiub, Abu & Mohiuddin Chowdhury, Abu Taiub Mohammed & Shahbaz, Mohammad & Karim, Md & Islam, Jahirul & Dan, Guo & Shuixiang, He. (2020). "A comparative observational study on Ivermectin- Doxycycline and Hydroxychloroquine-Azithromycin therapy on COVID19 patients".
2. Scientific publications: Ivermectin as antiviral of broad spectrum
Peer reviewed:
- https://www.nature.com/articles/s41429-020-0336-z
Review Article Published: 12 June 2020
Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen
Fatemeh Heidary & Reza Gharebaghi
The Journal of Antibiotics (2020)
- Patrì A, Fabbrocini G. Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment? J Am Acad Dermatol. 2020 Jun;82(6):e221. doi: 10.1016/j.jaad.2020.04.017. Epub 2020 Apr 10.
Zhou D, Dai SM, Tong Q. COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. J Antimicrob Chemother. 2020 Mar 20. pii: dkaa114. doi: 10.1093/jac/dkaa114. [Epub ahead of print]
- The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer, Antiviral Research, Volume 177, 2020, "http://www.sciencedirect.com/science/article/pii/S0166354219307211"
- Tu, Y.-F.; Chien, C.-S.; Yarmishyn, A.A.; Lin, Y.-Y.; Luo, Y.-H.; Lin, Y.-T.; Lai, W.-Y.; Yang, D.-M.; Chou, S.-J.; Yang, Y.-P.; Wang, M.-L.; Chiou, S.-H. A Review of SARS-CoV-2 and the Ongoing Clinical Trials. Int. J. Mol. Sci. 2020, 21, 2657. https://www.mdpi.com/1422-0067/21/7/2657/htm
- Raza, S.; Shahin, F.; Zhai, W.; Li, H.; Alvisi, G.; Yang, K.; Chen, X.; Chen, Y.; Chen, J.; Hu, C.; Chen, H.; Guo, A. Ivermectin Inhibits Bovine Herpesvirus 1 DNA Polymerase Nuclear Import and Interferes With Viral Replication. Microorganisms 2020, 8, 409. https://www.mdpi.com/2076-2607/8/3/409
- R. Choudhary, A.K. Sharma, Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance, New Microbes and New Infections, Volume 35, 2020,
http://www.sciencedirect.com/science/article/pii/S2052297520300366 - Angela Patrì, Gabriella Fabbrocini, Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?,
Journal of the American Academy of Dermatology, 2020, http://www.sciencedirect.com/science/article/pii/S0190962220305570 - Mike Bray, Craig Rayner, François Noël, David Jans, Kylie Wagstaff,
Ivermectin and COVID-19: a report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses, Antiviral Research, 2020, http://www.sciencedirect.com/science/article/pii/S0166354220302199
"Ivermectin’s key direct target in mammalian cells
is a not a viral component, but a host protein important in
intracellular transport (Yang et al., 2020);
the fact that it is a host-directed agent (HDA) is almost certainly the
basis of its broad-spectrum activity against a number of different RNA
viruses in vitro (Tay et al., 2013; Yang et al., 2020).
The way a HDA can reduce viral load is by inhibiting a key cellular
process that the virus hijacks to enhance infection by suppressing the
host antiviral response. Reducing viral load by even a modest amount by
using a HDA at low dose early in infection can be the key to enabling
the body’s immune system to begin to mount the full antiviral response
before the infection takes control."
- Leon Caly, Julian D. Druce, Mike G. Catton, David A. Jans, Kylie M. Wagstaff, The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro, Antiviral Research, Volume 178, 2020, http://www.sciencedirect.com/science/article/pii/S0166354220302011
- Hiroshi Maruta, Hong He, PAK1-blockers: Potential Therapeutics against COVID-19, Medicine in Drug Discovery, Volume 6, 2020,
http://www.sciencedirect.com/science/article/pii/S2590098620300269 - Kylie M. WAGSTAFF, Haran SIVAKUMARAN, Steven M. HEATON, David HARRICH and David A. JANS Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus Biochem. J. (2012) 443, 851–856. doi:10.1042/BJ20120150
- Lucia Romani, Ph,D. Michael Marks, PhD Oliver Sokana, MPH Titus Nasi, MCHBakaai Kamoriki Billie Cordell, MPH Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial. The Lancet. Volume 19, ISSUE 5, P510-518, May 01, 2019 https://doi.org/10.1016/S1473-3099(18)30790-4
- Crump, A. Ivermectin: enigmatic multifaceted ‘wonder’ drug continues to surprise and exceed expectations. J Antibiot 70, 495–505 (2017). https://doi.org/10.1038/ja.2017.11
spectrum specific inhibitor of importin α/β-mediated nuclear trans-
port and demonstrates antiviral activity against several RNA viruses by
blocking the nuclear trafficking of viral proteins. It has been shown to
have potent antiviral action against HIV-1 and dengue viruses, both of
which are dependent on the importin protein superfamily for several
key cellular processes. Ivermectin may be of import in disrupting
HIV-1 integrase in HIV-1 as well as NS-5 (non-structural protein 5)
polymerase in dengue viruses"
- Omura S, Crump A. Ivermectin: panacea for resource-poor communities?
Trends Parasitol. 2014 Sep;30(9):445-55. doi: 10.1016/j.pt.2014.07.005. Epub 2014 Aug 12.
2. Testimonials from Medical Doctors
- IVERMECTINA y sus resultados contra el COVID-19 (Entrevista al Dr. Walter Mogrovejo) https://www.facebook.com/clinicadelinca/videos/537089977005481/?t=0
- Ivermectina, La fase en que deben ser tratados los pacientes con dicho tratamiento https://youtu.be/tw1hDAiwZQQ
- Entrevista al Dr. Tavárez Capellán - Ivermectina para tratar COVID-19
- Entrevista al Dr. Maguiña, Ivermectina contra COVID-19?.
3. General articles in international press
- Fórmula eficaz que noqueó al virus ‘COVID-19’ en el Amazonas peruano.
https://www.connuestroperu.com/actualidad/entrevistas/65760-el-verdadero-comando-covid-19-de-iquitos-medicos-independientes-lograron-contener-el-azote-del-coronavirus-no-el-minsa-ni-essalud
El verdadero Comando COVID-19 de Iquitos: médicos independientes lograron contener el azote del coronavirus, no el Minsa ni Essalud
Entrevistas 13 Junio 2020
https://cnnespanol.cnn.com/2020/06/10/alerta-peru-da-impulso-a-hidroxicloroquina-e-ivermectina-como-tratamiento-para-covid-19/
Perú da impulso a hidroxicloroquina e ivermectina como tratamiento para covid-19
Por Kiarinna Parisi
17:17 ET(21:17 GMT) 10 junio, 2020
https://andina.pe/agencia/noticia-buena-iniciativa-libertad-producira-150000-dosis-ivermectina-801434.aspx
¡Buena iniciativa! La Libertad producirá 150,000 dosis de ivermectina
El medicamento se producirá en laboratorio del centro de salud de Pueblo Libre
http://www.laindustria.pe/nota/16227-la-respuesta-ha-sido-tarda-en-el-per-para-usar-la-ivermectina
TRUJILLO
Publicada el 14/06/2020 - 02:12 PM
La respuesta ha sido tardía en el Perú para usar la Ivermectina
Médico trujillano Gustavo Elera cree que este fármaco debió emplearse con mayor anticipación para tratarla covid-19, lo que hubiera evitado la pérdida de muchas vidas.
https://www.explica.co/peru-boosts-hydroxychloroquine-and-ivermectin-as-treatment-for-covid-19/
June 11, 2020
Peru boosts hydroxychloroquine and ivermectin as treatment for covid-19
Bolivia authorizes the use of ivermectin against covid-19 3:53
https://terrabrasilnoticias.com/medicamento-ivermectina-elimina-97-do-covid-19-dentro-da-celula-em-48h-diz-infectologista/
Medicamento ivermectina elimina 97% do COVID-19 dentro da célula em 48h, diz infectologista
Terra Brasil Notícias junho 6, 2020 47
http://www.laindustria.pe/nota/16073-la-ivermectina-fue-creada-para-el-tratamiento-de-humanos
TRUJILLO
Publicada el 07/06/2020 - 04:18 PM
“La Ivermectina fue creada para el tratamiento de humanos”
El médico trujillano Gustavo Elera ha frenado en seco al coronavirus en unos mil 200 pacientes en Chanchamayo con este fármaco, muy empleado en medicina veterinaria.
https://diariouno.pe/medidas-fracasaron-porque-pensaron-en-la-clase-media
Medidas fracasaron porque pensaron en la clase media
EXPERTO EPIDEMIÓLOGO SERGIO RECUENCO, SOBRE LA PANDEMIA:
Publicado hace 1 semana
el 14 junio, 2020
Web
https://www.trialsitenews.com/how-a-grass-roots-health-movement-led-to-acceptance-of-ivermectin-as-a-covid-19-therapy-in-peru/
How a Grass Roots Health Movement Led to Acceptance of Ivermectin as a COVID-19 Therapy in Peru
Jun 12, 2020 | Blog, COVID-19, Hydroxychloroquine, Ivermectin, News, Peru, SARS-CoV-2
Videos
https://youtu.be/u6VPZaXnlPY
Clinical Trials and Research News Weekly Roundup | S2 E24 | Ivermectin in Peru
15 jun. 2020 - Local Doctor Tries New Coronavirus Drug Treatment
Dr. Jean-Jacques Rajter is working on a new treatment for COVID-19 patients, pioneering the use of an anti-parasitic drug called Ivermectin.
That’s the first thing Dr. Jean-Jacques Rajter wants everyone to know about the treatment he’s using on his COVID-19 patients at Broward Health Medical Center.
“Ideally, the sooner you get to them, the better off they are,” said Dr. Rajter, a pulmonologist.
He and his wife, who is also a pulmonologist, are pioneering the use of an anti-parasitic drug called Ivermectin to fight the novel coronavirus.
“If we get to these people early, and what I mean by that is if their oxygen requirements are less than 50%, I’ve had nearly a 100% response rate, they all improve, if they’re on more oxygen than that, then it becomes a little more varied, some people, they don’t respond anymore because they are too far advanced,” explained Dr. Rajter.
Two weeks ago, Dr. Rajter started adding Ivermectin to the cocktail of drugs currently used to treat COVID-19: hydroxychloraquine, azithromycin, and zinc sulfate.
https://www.nbcmiami.com/news/local/local-doctor-tries-new-coronavirus-drug-treatment/2219465/ - Ivermectin is a winner treating Covid-19 patients in Dominic Republic Dolores Vicioso Apr 24, 2020 at 9:52 AM https://dr1.com/wordpress/2020/04/24/ivermectin-is-a-winner-treating-covid-19-patients-in-dr/?fbclid=IwAR0phmg5Jfw4GowOaQZtg8aY7nupQYC1GLwbQ85-bnRbgs92rdtkJH25s5k
No hay comentarios.:
Publicar un comentario